Related Experiment Videos
Molecular cloning and genomic structure of the betaTRCP2 gene on chromosome 5q35.1
J Koike1, N Sagara, H Kirikoshi
1Genetics Division, National Cancer Center Research Institute, Tsukiji 5-chome, Chuo-ku, Tokyo, 104-0045, Japan.
Abstract:
Beta-catenin, IkappaBalpha, and HIV Vpu are recruited to the ubiquitin-proteasome degradation pathway by betaTRCP, one of the components of the ubiquitin ligase complex. betaTRCP2, a related gene of betaTRCP, was cloned and characterized. Three isoforms, betaTRCP2A, betaTRCP2B, and betaTRCP2C, were identified. All of these betaTRCP2 isoforms consist of an F-box and seven WD repeats. Human betaTRCP2A shows 86% total amino acid identity with human betaTRCP. betaTRCP2 mRNA of 4.5 kb in size was detected almost ubiquitously. Sequence analyses on betaTRCP2 genomic clones revealed that the betaTRCP2 gene consists of at least 14 exons. Exons 1 and 4-14 are shared among all betaTRCP2 isoforms. betaTRCP2A of 508 amino acids lacks exons 2 and 3, betaTRCP2B of 529 amino acids contains exon 3, and betaTRCP2C of 542 amino acids contains exon 2. These results indicate that three betaTRCP2 isoforms are transcribed due to alternative splicing. The betaTRCP2 gene has been mapped to human chromosome 5q35.1 by fluorescence in situ hybridization.
Insights
The betaTRCP2 gene encodes three protein isoforms (betaTRCP2A, B, and C) generated through alternative splicing. This gene, crucial for the ubiquitin-proteasome pathway, is located on human chromosome 5q35.1.
Area of Science:
- Molecular Biology
- Genetics
- Cell Biology
Background:
- Beta-transducin repeat-containing protein (betaTRCP) is a key component of the ubiquitin ligase complex, mediating the degradation of various proteins via the ubiquitin-proteasome pathway.
- Beta-catenin, IkappaBalpha, and HIV Vpu are examples of substrates recruited for degradation by betaTRCP.
- The identification and characterization of related genes are essential for understanding the complexity of protein regulation.
Purpose of the Study:
- To clone and characterize betaTRCP2, a gene related to betaTRCP.
- To identify and describe the different isoforms of betaTRCP2.
- To investigate the genomic structure and chromosomal localization of the betaTRCP2 gene.
Main Methods:
- Gene cloning and characterization.
- Isoform identification through sequence analysis.
- mRNA expression analysis.
- Genomic DNA sequencing and analysis.
- Fluorescence in situ hybridization (FISH) for gene mapping.
Main Results:
- Three betaTRCP2 isoforms (betaTRCP2A, betaTRCP2B, and betaTRCP2C) were identified, all containing an F-box and seven WD repeats.
- Human betaTRCP2A shares 86% amino acid identity with human betaTRCP.
- BetaTRCP2 mRNA (4.5 kb) is ubiquitously expressed.
- The betaTRCP2 gene comprises at least 14 exons, with alternative splicing accounting for the different isoforms.
- The betaTRCP2 gene was mapped to human chromosome 5q35.1.
Conclusions:
- The betaTRCP2 gene produces at least three distinct isoforms (A, B, and C) through alternative splicing.
- These isoforms likely play roles in the ubiquitin-proteasome pathway, similar to betaTRCP.
- The characterization of betaTRCP2 and its isoforms provides insights into the regulation of protein degradation.
- The chromosomal localization of betaTRCP2 offers a basis for further genetic studies.